Literature DB >> 9120926

Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value.

J Irani1, P Levillain, J M Goujon, D Bon, B Doré, J Aubert.   

Abstract

PURPOSE: We attempted to identify morphological parameters of benign prostatic hyperplastic inflammation that correlate with pre-biopsy prostate specific antigen (PSA) concentrations.
MATERIALS AND METHODS: Patients undergoing prostate biopsy at our department were prospectively studied between January 1995 and January 1996. preoperative blood and 24-hour urine samples were measured for PSA. Biopsy samples harboring exclusively benign prostatic tissue were graded on a 4-point scale for inflammation (0-no inflammatory cells, 1-scattered inflammatory cell infiltrate, 2-nonconfluent lymphoid nodules and 3-large inflammatory areas with confluence of infiltrate) and aggressiveness (0-no contact between inflammatory cells and glandular epithelium; 1-contact between inflammatory cell infiltrate and glandular epithelium; 2-clear but limited, that is less than 25% of the examined material, glandular epithelium disruption, and 3-glandular epithelium disruption on more than 25% of the examined material).
RESULTS: A total of 66 patients with exclusively benign prostatic tissue on prostate biopsies was analyzed. Difference between inflammation graded groups was not significant when considering serum or urinary PSA. There was a significant correlation between aggressiveness grading and serum PSA (rho = 0.51, p < 0.0001), whereas aggressiveness grading and urinary PSA did not correlate (rho = -0.06, p = 0.6).
CONCLUSIONS: Prostatic subclinical inflammation is not associated with high urinary PSA. Unless associated with glandular epithelial disruption, density of prostatic interstitial inflammatory cell infiltrate is not significantly correlated with serum PSA concentration. We believe that this issue should be considered when interpreting a prostate biopsy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9120926     DOI: 10.1016/s0022-5347(01)64957-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  33 in total

Review 1.  Histopathology reporting of prostate needle biopsies. 2005 update.

Authors:  Rodolfo Montironi; Remigio Vela Navarrete; Antonio Lopez-Beltran; Roberta Mazzucchelli; Gregor Mikuz; Aldo V Bono
Journal:  Virchows Arch       Date:  2006-04-22       Impact factor: 4.064

2.  The correlation between serum prostate specific antigen levels and asymptomatic inflammatory prostatitis.

Authors:  Cuneyt Ozden; Ozdem Levent Ozdal; Ozer Guzel; Ozge Han; Selda Seckin; Ali Memis
Journal:  Int Urol Nephrol       Date:  2006-11-17       Impact factor: 2.370

3.  [Modification of the histopathologic degree of inflammation in asymptomatic prostatitis (NIH IV) by moxifloxacin].

Authors:  T Bschleipfer; F M E Wagenlehner; W Weidner
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

4.  Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancer.

Authors:  M H Umbehr; B Gurel; T J Murtola; S Sutcliffe; S B Peskoe; C M Tangen; P J Goodman; I M Thompson; S M Lippman; M S Lucia; H L Parnes; C G Drake; W G Nelson; A M De Marzo; E A Platz
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-05-05       Impact factor: 5.554

5.  Intratumoral inflammation is associated with more aggressive prostate cancer.

Authors:  Joseph C Klink; Lionel L Bañez; Leah Gerber; Amy Lark; Robin T Vollmer; Stephen J Freedland
Journal:  World J Urol       Date:  2013-04-02       Impact factor: 4.226

6.  Heme oxygenase levels and metaflammation in benign prostatic hyperplasia patients.

Authors:  Giorgio Ivan Russo; Luca Vanella; Tommaso Castelli; Sebastiano Cimino; Giulio Reale; Daniele Urzì; Giovanni Li Volti; Mauro Gacci; Marco Carini; Fabio Motta; Rosario Caltabiano; Lidia Puzzo; Valeria Sorrenti; Giuseppe Morgia
Journal:  World J Urol       Date:  2015-11-30       Impact factor: 4.226

7.  Is histological prostate inflammation in an initial prostate biopsy a predictor of prostate cancer on repeat biopsy?

Authors:  Bu Hyeon Yun; Eu Chang Hwang; Ho Song Yu; Hoseok Chung; Sun-Ouck Kim; Seung Il Jung; Taek Won Kang; Dong Deuk Kwon; Kwangsung Park; Chan Choi
Journal:  Int Urol Nephrol       Date:  2015-06-14       Impact factor: 2.370

8.  Preventive effects of oligomerized polyphenol on estradiol-induced prostatitis in rats.

Authors:  Dong Suk Kim; Eun Jin Lee; Kang Su Cho; So Jung Yoon; Young Hoon Lee; Sung Joon Hong
Journal:  Yonsei Med J       Date:  2009-06-23       Impact factor: 2.759

9.  The effect of intraprostatic chronic inflammation on benign prostatic hyperplasia treatment.

Authors:  Young Kee Kwon; Mi Sun Choe; Kyung Won Seo; Chol Hee Park; Hyuk Soo Chang; Byung Hoon Kim; Chun Il Kim
Journal:  Korean J Urol       Date:  2010-04-20

10.  Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mL.

Authors:  Stéphane Bolduc; Louis Lacombe; Alain Naud; Mireille Grégoire; Yves Fradet; Roland R Tremblay
Journal:  Can Urol Assoc J       Date:  2007-11       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.